Cigna has announced that it will acquire Express Scripts in a $67 billion deal. The deal brings health benefits and pharmacy benefits under the same roof and is the latest in a string of acquisitions and mergers as the industry attempts to address health costs.
Cigna has announced that it will acquire Express Scripts in a $67 billion deal.
The deal will consist of $48.75 billion in cash and 0.2434 shares of stock of the combined company per Express Scripts share, according to a press release from Cigna. As part of the acquisition, Cigna will be assuming $15 billion of the pharmacy benefit manager’s debt.
“Cigna’s acquisition of Express Scripts brings together 2 complementary customer-centric services companies, well-positioned to drive greater quality and affordability for customers,” said David M. Cordani, president and chief executive officer, Cigna. “The combination accelerates Cigna’s enterprise mission of improving the health, well-being, and sense of security of those we serve, and in turn, expanding the breadth of services for our customers, partners, clients, health plans, and communities.”
According to Cigna, the acquisition will:
The deal brings health benefits and pharmacy benefits under the same roof and is the latest in a string of acquisitions and mergers as the industry attempts to address health costs. Just a few months back, CVS Health announced its proposal to purchase Aetna, voicing its intent to “remake the consumer healthcare experience.”
In 2015, Anthem was set to purchase Cigna for $54 billion, less than a month after Aetna announced it was purchasing Humana for $37, leaving the industry preparing to go from 5 big insurers to just 3. Two years later, the proposed mergers fell apart as judges blocked the deals, ruling they would have anticompetitive effects and would be harmful to consumers.
Following the acquisition announcement, the National Community Pharmacists Association (NCPA) weighed in with a statement on the the dangers of consolidation in healthcare.
"Consolidation among health care giants leads to fewer choices for patients and plan sponsors,” NCPA CEO B. Douglas Hoey, Pharmacist, MBA, said in a statement. “In addition, companies make claims of cost savings that will benefit patients and health plan sponsors, but the available evidence from previous consolidations suggests otherwise."
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen